Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) does not appear to affect the Mirena coil. Because the Mirena works locally inside the uterus rather than being absorbed through the gut, it is not subject to the absorption interaction that tirzepatide raises for oral contraceptives. That said, there are still things worth knowing before you start treatment — and your prescriber should always have the full picture of every medicine you use. Mounjaro is a prescription-only medicine; a clinician assesses suitability before any prescription is issued.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide slows the rate at which the stomach empties. That matters for medicines taken by mouth because slower transit means variable absorption, the drug may peak at a different time, or the effective dose reaching the bloodstream may be lower than expected. This is the mechanism behind NHS guidance that women using oral contraceptive pills should use an additional barrier method for the first four weeks of Mounjaro and for four weeks after every dose increase, as noted on NHS England's weight-management injections guidance.
The Mirena coil (formally the levonorgestrel intrauterine system) works differently. It sits inside the uterus and releases a small, continuous amount of levonorgestrel directly into the uterine lining. Almost none of it enters the general circulation, and none of it travels through the gut. Gastric emptying is simply not part of how it works. That is the core reason the oral-pill interaction warning does not carry over to the Mirena.
If you are curious about how tirzepatide more broadly interacts with hormonal contraception, our page on Mounjaro and the Mirena coil covers the topic in more depth.
The Mirena already changes periods for most people, lighter, irregular, or absent bleeding is normal and expected. Tirzepatide adds its own layer. Significant weight loss can shift hormonal patterns: oestrogen stored in fat tissue falls as that tissue reduces, and for some women this temporarily affects their cycle. If you notice new or unusual bleeding after starting Mounjaro, it is genuinely difficult to attribute that to the coil, to the treatment, or to the weight-loss process itself without a clinical assessment.
There is also a separate question worth flagging: if you have been using the Mirena partly for contraception and you lose a meaningful amount of weight, your fertility may return sooner than expected, or differ from what you assumed before treatment. The MHRA advises using effective contraception while taking tirzepatide and through a wash-out period before trying to conceive. For most Mirena users this is already covered, but it is worth confirming with your GP that your contraceptive cover is still appropriate for your circumstances, and our dedicated page on Mounjaro and the coil goes into further detail on exactly that point.
Changes to periods more broadly are something a lot of people on tirzepatide notice. Our page on how Mounjaro can affect your period looks at what the evidence shows.
Before starting Mounjaro, list every medicine, contraceptive and medical device you use. The Mirena counts. It is not because there is a known interaction to manage, it is because a prescriber building your full clinical picture needs the complete list. Our prescribers at nume review every consultation personally, and that review includes your contraception.
If, after starting treatment, you notice any of the following, speak to a clinician promptly: unusual pain in your lower abdomen, unexpected heavy bleeding, signs that the coil may have shifted (your GP can check the threads), or any other change that feels new and unexplained. None of these are common occurrences linked to tirzepatide, but they are always worth investigating quickly regardless of what medicine you are on.
The NHS tirzepatide information page is a reliable reference for what to watch for during treatment generally. For questions specific to how tirzepatide sits alongside other medicines and devices, your prescribing clinician is the right person to ask, not a forum and not a guess.
If you are also on HRT, there is a related consideration: NHS England advises discussing transdermal HRT (patches or gels rather than tablets) with your doctor while on tirzepatide, for the same gut-absorption reason that applies to oral tablets. Our page on Mounjaro and HRT covers that specifically.
For anyone weighing up the broader question of contraception and this treatment, the effect of Mounjaro on the coil is a question our prescribers hear regularly, it reflects how seriously people take getting this right before they begin.
A brief practical note on timing: if you are considering starting treatment and want it reviewed before the school-run rush, nume submits consultations for same-day clinical review on working days, a real prescriber reads your answers, not software. Our Mounjaro pricing page sets out what a private prescription includes, if cost is part of your thinking.
Treatment is one part of the picture. For a broader overview of the weight-management options a prescriber might discuss with you, our weight-loss overview explains how the different approaches fit together.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.